arrow
K

Keren M. Rabinowitz

Tel Aviv University
H指数:14
被引数:950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Mediterranean diet in patients with early Crohn's disease - feasibility and drivers of adherence in Israel and India: Results from the IBDMED randomized controlled trial

地中海饮食在早期克罗恩病患者中的应用——以色列和印度的依从性可行性与驱动因素:IBDMED随机对照试验的结果

2026-01-010
PRE
The Mediterranean diet improves clinical and inflammatory outcomes in patients with early Crohn's Disease: Results from the IBDMED randomized controlled trial

地中海饮食改善早期克罗恩病患者的临床和炎症结局:IBDMED随机对照试验结果

2026-01-010
PRE
Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment lines

一线和高级疗法对慢性炎症性储袋疾病的药物持久性:一项跨越顺序治疗线的队列研究

2025-11-120
PRE
Factors Associated With Biologic Therapy After Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis

Fischman, M.; Godny, L.; Friedenberg, A.; Barkan, R.; White, I.; Wasserberg, N.; Rabinowitz, K.; Avni-Biron, I.; Banai, H.; Snir, Y.; 等. 与溃疡性结肠炎患者回肠储袋肛管吻合术后生物治疗相关的因素. Inflamm. Bowel Dis. 2024, 31, izae272. [Google Scholar] [CrossRef]

2024-11-012
OA
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
2023-07-200
OAAI
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
2022-10-291
OAAI
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
2022-07-2610
OAAI
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

用抗tnf α 治疗的炎症性肠病患者对新型冠状病毒肺炎mRNA疫苗的血清学反应较低

2022-02-0170
OAAI